Suppr超能文献

构象约束肽靶向变构激酶二聚体界面并抑制 EGFR 激活。

Conformationally constrained peptides target the allosteric kinase dimer interface and inhibit EGFR activation.

机构信息

Department of Pharmaceutical and Biomedical Sciences, University of Georgia, College of Pharmacy, 240 W. Green St, Athens, GA 30602, USA.

Department of Biochemistry and Molecular Biology, University of Georgia, 120 Green St, Athens, GA 30602, USA; Institute of Bioinformatics, University of Georgia, 120 Green St, Athens, GA 30602, USA.

出版信息

Bioorg Med Chem. 2018 Mar 15;26(6):1167-1173. doi: 10.1016/j.bmc.2017.08.051. Epub 2017 Sep 5.

Abstract

Although EGFR is a highly sought-after drug target, inhibitor resistance remains a challenge. As an alternative strategy for kinase inhibition, we sought to explore whether allosteric activation mechanisms could effectively be disrupted. The kinase domain of EGFR forms an atypical asymmetric dimer via head-to-tail interactions and serves as a requisite for kinase activation. The kinase dimer interface is primarily formed by the H-helix derived from one kinase monomer and the small lobe of the second monomer. We hypothesized that a peptide designed to resemble the binding surface of the H-helix may serve as an effective disruptor of EGFR dimerization and activation. A library of constrained peptides was designed to mimic the H-helix of the kinase domain and interface side chains were optimized using molecular modeling. Peptides were constrained using peptide "stapling" to structurally reinforce an alpha-helical conformation. Peptide stapling was demonstrated to notably enhance cell permeation of an H-helix derived peptide termed EHBI2. Using cell-based assays, EHBI2 was further shown to significantly reduce EGFR activity as measured by EGFR phosphorylation and phosphorylation of the downstream signaling substrate Akt. To our knowledge, this is the first H-helix-based compound targeting the asymmetric interface of the kinase domain that can successfully inhibit EGFR activation and signaling. This study presents a novel, alternative targeting site for allosteric inhibition of EGFR.

摘要

虽然 EGFR 是一个备受关注的药物靶点,但抑制剂耐药性仍然是一个挑战。作为激酶抑制的替代策略,我们试图探索变构激活机制是否能够有效地被破坏。EGFR 的激酶结构域通过头到尾相互作用形成一个非典型的不对称二聚体,是激酶激活的必要条件。激酶二聚体界面主要由一个激酶单体的 H 螺旋和第二个单体的小 lobe 形成。我们假设,设计成类似于 H 螺旋结合表面的肽可能成为有效破坏 EGFR 二聚化和激活的物质。设计了一个约束肽文库来模拟激酶结构域的 H 螺旋,使用分子建模优化了界面侧链。使用肽“订书钉”来约束肽,以增强其α螺旋构象。肽订书钉显著提高了一种称为 EHBI2 的 H 螺旋衍生肽的细胞通透性。通过细胞测定,EHBI2 进一步显示可显著降低 EGFR 活性,如 EGFR 磷酸化和下游信号底物 Akt 的磷酸化所测量的。据我们所知,这是第一个靶向激酶结构域不对称界面的基于 H 螺旋的化合物,可以成功抑制 EGFR 的激活和信号转导。本研究提出了一种新的、替代的变构抑制 EGFR 的靶点。

相似文献

1
Conformationally constrained peptides target the allosteric kinase dimer interface and inhibit EGFR activation.
Bioorg Med Chem. 2018 Mar 15;26(6):1167-1173. doi: 10.1016/j.bmc.2017.08.051. Epub 2017 Sep 5.
3
A highly efficient peptide substrate for EGFR activates the kinase by inducing aggregation.
Biochem J. 2013 Aug 1;453(3):337-44. doi: 10.1042/BJ20130537.
5
Computational modeling of allosteric communication reveals organizing principles of mutation-induced signaling in ABL and EGFR kinases.
PLoS Comput Biol. 2011 Oct;7(10):e1002179. doi: 10.1371/journal.pcbi.1002179. Epub 2011 Oct 6.
7
Inhibiting EGFR dimerization using triazolyl-bridged dimerization arm mimics.
PLoS One. 2015 Mar 19;10(3):e0118796. doi: 10.1371/journal.pone.0118796. eCollection 2015.
8
Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein.
J Biol Chem. 2011 May 27;286(21):18756-65. doi: 10.1074/jbc.M110.206193. Epub 2011 Mar 30.
9
A Stapled Peptide Mimic of the Pseudosubstrate Inhibitor PKI Inhibits Protein Kinase A.
Molecules. 2019 Apr 20;24(8):1567. doi: 10.3390/molecules24081567.
10
Regulation of Kinase Activity in the Caenorhabditis elegans EGF Receptor, LET-23.
Structure. 2018 Feb 6;26(2):270-281.e4. doi: 10.1016/j.str.2017.12.012. Epub 2018 Jan 18.

引用本文的文献

2
Targeted Degradation of Protein Kinase A via a Stapled Peptide PROTAC.
ACS Chem Biol. 2024 Sep 20;19(9):1888-1895. doi: 10.1021/acschembio.4c00237. Epub 2024 Aug 13.
3
Design and synthesis of Nrf2-derived hydrocarbon stapled peptides for the disruption of protein-DNA-interactions.
PLoS One. 2022 Jun 22;17(6):e0267651. doi: 10.1371/journal.pone.0267651. eCollection 2022.
4
Allosteric inhibition of LRRK2, where are we now.
Biochem Soc Trans. 2020 Oct 30;48(5):2185-2194. doi: 10.1042/BST20200424.
5
Current Approaches in NSCLC Targeting K-RAS and EGFR.
Int J Mol Sci. 2019 Nov 14;20(22):5701. doi: 10.3390/ijms20225701.
6
A Stapled Peptide Mimic of the Pseudosubstrate Inhibitor PKI Inhibits Protein Kinase A.
Molecules. 2019 Apr 20;24(8):1567. doi: 10.3390/molecules24081567.
7
Targeted Inhibition of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 with a Constrained J Domain-Derived Disruptor Peptide.
ACS Infect Dis. 2019 Apr 12;5(4):506-514. doi: 10.1021/acsinfecdis.8b00347. Epub 2019 Feb 18.
8
Altered conformational landscape and dimerization dependency underpins the activation of EGFR by C-4 loop insertion mutations.
Proc Natl Acad Sci U S A. 2018 Aug 28;115(35):E8162-E8171. doi: 10.1073/pnas.1803152115. Epub 2018 Aug 13.

本文引用的文献

2
Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6.
Nat Struct Mol Biol. 2015 Sep;22(9):703-711. doi: 10.1038/nsmb.3074. Epub 2015 Aug 17.
3
Design of a selenylsulfide-bridged EGFR dimerization arm mimic.
Bioorg Med Chem. 2015 Jun 15;23(12):2761-6. doi: 10.1016/j.bmc.2015.03.040. Epub 2015 Mar 20.
4
Inhibiting EGFR dimerization using triazolyl-bridged dimerization arm mimics.
PLoS One. 2015 Mar 19;10(3):e0118796. doi: 10.1371/journal.pone.0118796. eCollection 2015.
5
PKA-type I selective constrained peptide disruptors of AKAP complexes.
ACS Chem Biol. 2015 Jun 19;10(6):1502-10. doi: 10.1021/acschembio.5b00009. Epub 2015 Mar 25.
6
Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.
Cancer Discov. 2015 May;5(5):534-49. doi: 10.1158/2159-8290.CD-14-0750. Epub 2015 Mar 3.
7
A structural perspective on the regulation of the epidermal growth factor receptor.
Annu Rev Biochem. 2015;84:739-64. doi: 10.1146/annurev-biochem-060614-034402. Epub 2015 Jan 26.
10
ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors.
Pharmacol Res. 2014 Sep;87:42-59. doi: 10.1016/j.phrs.2014.06.001. Epub 2014 Jun 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验